{"path":"Images/Pasted image 20240410213306.png","text":"TABLE 16. Suggested Dosing Regimens for Prophylaxis Against Pregnancy-Related VTE ACOG™” ACCP™ NPMS\" Prophylactic UFH 5000-10,000 U every 12 h 5000 U every 12h +5000-7500 U every 12 h in Ist trimester * 5000-7500 U every 12 h in 1st trimester «7500-10,000 U every 12 h in 2nd trimester * 7500-10,000 U every 12 h in 2nd trimester 10,000 U every 12 h in the 3rd trimester + 10,000 U every 12 h in the 3rd trimester Hospitalized antepartum patients may receive unless aPTT is elevated 5000 U every 12 h Minidose: 5000 U every 12 h Prophylactic LMWH Dalteparin 5000 U once daily Dalteparin 5000 U once daily Dalteparin 5000 U once daily Tinzaparin 4500 U once daily Tinzaparin 4500 U once daily Tinzaparin 4500 U once daily Enoxaparin 40 mg once daily Enoxaparin 40 mg once daily Enoxaparin 40 mg once daily At extremes of body weight, modification At extremes of body weight, At extremes of body weight, modification of dose may be required modification of dose may be required of dose may be required Therapeutic UFH 210,000 U every 12 h in doses adjusted Every 12-h dose adjusted to targeta 210,000 U BID adjusted to midinterval aPTT to target aPTT in the therapeutic range midinterval aPTT in the therapeutic range Therapeutic-dose Dalteparin 200 U/kg QD or dalteparin Dalteparin 200 U/kg QD or 100 U/kg Dalteparin 200 U/kg QD LMWH* 100 Ukg every 12 h every 12h Tinzaparin 175 U/kg QD Tinzaparin 175 U/kg QD Tinzaparin 175 U/kg QD Enoxaparin 1 mg/kg every 12 h Enoxaparin 1 mg/kg every 12 h Enoxaparin 1 mg/kg every 12 h *LMWH adjusted to a peak anti—factor Xa level of 0.5 to 1.0 U/mL (measured 3—4 hours after dose) or trough levels of 0.2 to 0.4 U/mL (measured 12 hours after dose). Anti—factor Xa assay must be calibrated to specific LMWH.","libVersion":"0.3.2","langs":"eng"}